Benefit on Chronic Pain of Early Screening and Management of Patients With Persistent Postoperative Pain at 3 Months
NCT ID: NCT07160595
Last Updated: 2025-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
2052 participants
INTERVENTIONAL
2025-11-30
2028-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Improving the screening of patients with chronic postoperative pain is therefore crucial. Our research has shown that early detection of postoperative neuropathic pain is possible using just two text messages (SMS), as early as three months after surgery. Early screening, combined with prompt management, can prevent pain from becoming chronic and mitigate its harmful effects.
Study design
This study is a cluster crossover randomized trial. All participating centers (n=16) will take part in two sequential study periods:
* Control Period: "Without early treatment at 3 months" During this period, patients with persistent postoperative pain-identified via SMS-will receive treatment at 6 months. This reflects the current standard of care for patients with postoperative pain.
* Intervention Period: "With early treatment at 3 months" During this period, patients with persistent postoperative pain-identified via SMS-will receive early treatment starting at 3 months.
Study Population
The study will include patients undergoing the following minor surgical procedures:
* Inguinal hernia repair
* Breast reduction
* Mastectomy with lymph node dissection
* Knee arthroscopy
* Knee ligament reconstruction
Study Schedule Recruitment Period: 24 months Patient Follow-up: 6 months Total Estimated Study Duration: 30 months
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Help With Early Detection of Postoperative Neuropathic Pain Using SMS After Ambulatory Surgery
NCT04313855
Characterization of Post-operative Pain Trajectories Over Seven Days and Links With Chronicity
NCT02599233
Assessment of the Development of Postoperative Persistent Postoperative Pain
NCT05370924
Neuropathic Evaluation of Postoperative Pain
NCT02826317
Evaluation of Pain Trajectories After Surgery and Their Potential Relationship With Chronicity at 3 Months
NCT05326737
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
* Control Period: "Without early treatment at 3 months" During this period, patients with persistent postoperative pain-identified via SMS-will receive treatment at 6 months. This reflects the current standard of care for patients with postoperative pain.
* Intervention Period: "With early treatment at 3 months" During this period, patients with persistent postoperative pain-identified via SMS-will receive early treatment starting at 3 months.
Each center will be randomized into one of two sequences: "control period followed by intervention period" or "intervention period followed by control period."
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control period 'without early intervention at 3 months'
During this period, patients with persistent post-operative pain, identified through SMS screening, will be treated at 6 months (this reflects the current standard experience for patients with postoperative pain).
No interventions assigned to this group
Intervention period 'with early intervention at 3 months'
During this period, patients with persistent post-operative pain, identified through SMS screening, will receive early treatment starting at 3 months.
Early management of postoperative pain at 3 months detected using sms
During this period, patients with persistent post-operative pain, identified through SMS screening, will receive early treatment starting at 3 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early management of postoperative pain at 3 months detected using sms
During this period, patients with persistent post-operative pain, identified through SMS screening, will receive early treatment starting at 3 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Inguinal hernia repair, regardless of the surgical technique used
* Breast reduction
* Mastectomy with or without reconstruction but with lymph node dissection
* Knee arthroscopy or knee ligamentoplasty
* Patients with a smartphone
* French-speaking patients
* Patients affiliated with a social security
* Patients who have given their free and informed verbal consent
Exclusion Criteria
* Patients subject to legal protection measures
* Patients deprived of their liberty
* Pregnant, labouring or breastfeeding patients
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Hôpital Saint-Joseph
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Prive Claude Galien
Boussy-Saint-Antoine, , France
Hospices Civils de Lyon
Lyon, , France
Clinique Jules Verne
Nantes, , France
Hôpital Privé du confluent Santé Atlantique
Nantes, , France
AP-HP : Hôpital de la Pitié Salpêtrière
Paris, , France
AP-HP : Hôpital Saint-Louis
Paris, , France
Clinique Drouot Remusat
Paris, , France
Clinique Geoffroy Saint Hilaire
Paris, , France
Hôpital de la Croix Saint-Simon
Paris, , France
Hôpital Paris Saint-Joseph
Paris, , France
Institut Curie : Hôpital de Paris
Paris, , France
Institut Mutualiste Montsouris
Paris, , France
Institut Curie : Hôpital de Saint Cloud
Saint-Cloud, , France
CHU de Saint-Etienne
Saint-Etienne, , France
Hôpital Foch
Suresnes, , France
CHU de Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID RCB
Identifier Type: OTHER
Identifier Source: secondary_id
731_DROPS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.